share_log

EXCLUSIVE: Pasithea Says 'PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity'

EXCLUSIVE: Pasithea Says 'PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity'

獨家報道:Pasithea説,PAS002有效地降低了疾病的嚴重程度,延緩了疾病的發作,同時也降低了復發的嚴重程度。
Benzinga Real-time News ·  2022/08/11 07:34

EXCLUSIVE: Pasithea Says 'PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity'

獨家報道:Pasithea説,PAS002有效地降低了疾病的嚴重程度,延緩了疾病的發作,同時也降低了復發的嚴重程度。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論